Andrew Fisher - 30 Oct 2024 Form 4 Insider Report for Verona Pharma plc (VRNA)

Role
General Counsel
Signature
/s/ Andrew Fisher
Issuer symbol
VRNA
Transactions as of
30 Oct 2024
Net transactions value
$0
Form type
4
Filing time
01 Nov 2024, 19:13:20 UTC
Previous filing
02 Apr 2024
Next filing
01 May 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VRNA Ordinary Shares Award $0 +300,000 $0.000000 300,000 30 Oct 2024 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reported securities are represented by American Depositary Shares ("ADSs"), each of which represents eight (8) Ordinary Shares of the Issuer.
F2 Represents an award of Restricted Share Units ("RSUs"), each of which represents a contingent right to receive one (1) Ordinary Share of the Issuer. The RSUs vest over four years, with 1/4th of the RSUs vesting on November 1, 2025 and the balance vesting in 12 equal quarterly installments thereafter.
F3 Consists of (i) 300,000 Ordinary Shares underlying Restricted Share Units, each of which represents a contingent right to receive one (1) Ordinary Share of the Issuer (which are represented by 37,500 ADSs).